|
Volumn 98, Issue 6, 2001, Pages 3618-3623
|
Live attenuated HIV vaccines: Predicting the tradeoff between efficacy and safety
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LIVE VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
DISEASE CONTROL;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MORTALITY;
PREDICTION;
PRIORITY JOURNAL;
THAILAND;
VACCINATION;
VIRUS STRAIN;
VIRUS TRANSMISSION;
ZIMBABWE;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
CONSUMER PRODUCT SAFETY;
HIV INFECTIONS;
HIV-1;
HUMANS;
MODELS, IMMUNOLOGICAL;
PREDICTIVE VALUE OF TESTS;
THAILAND;
VACCINES, ATTENUATED;
ZIMBABWE;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0035853080
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.061029998 Document Type: Article |
Times cited : (56)
|
References (46)
|